Evolent Health Marketing Mix
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Evolent Health Bundle
Built for Strategy. Ready in Minutes.
Evolent Health’s 4P snapshot reveals a care-centric product mix, value-driven pricing, targeted channel partnerships, and data-led promotions that scale provider enablement—discover the strategic levers behind their growth and competitive positioning. Get the full, editable Marketing Mix Analysis to save hours of research and use a presentation-ready framework for benchmarking, client work, or coursework. Instant access, practical insights, and ready-to-use templates.
Product
Value-Based Care Platform
Evolent Health’s Value-Based Care Platform combines clinical and financial data to help providers and payers shift to value models, supporting care management for 4.5M+ attributed lives as of 2025 and driving reported medical cost trend reductions up to 6% in client programs; it flags high-risk cohorts via predictive analytics, enables care coordination workflows, and links outcomes to risk-adjusted payment models to improve quality scores and lower total cost of care.
Specialty Care Management
Through Evolent Care Partners and the 2023 NIA acquisition, Evolent Health offers specialty care management in oncology, cardiology, and musculoskeletal health, targeting categories that drive ~60% of medical spend for many clients; programs use evidence-based clinical pathways and prior-authorizations to cut unnecessary utilization, with reported specialty cost savings of 8–12% in 2024 pilot clients and improved adherence to guideline care by 18 percentage points.
Identifi Proprietary Software
Identifi, Evolent Health’s central tech engine, aggregates claims, EHR, and SDOH data into a longitudinal patient view, powering care-manager workflow automation and delivering point-of-care analytics that raised care-team productivity by ~18% in 2024 and helped cut avoidable admissions by 6% in pilots; it’s pivotal for scaling admin efficiency across Evolent’s 2025 network managing ~1.2 million lives and for enabling data-driven decisions that support margin and quality targets.
Administrative and Clinical Services
Evolent Health’s Administrative and Clinical Services outsource claims processing, member services, and utilization management, cutting payer overhead—Evolent reported 2025 administrative cost reduction of ~12% for clients, per its 2025 investor update.
These services pair back-office functions with clinical oversight to maintain quality metrics like 90-day readmission reductions (client-reported 8% improvement) and 85% first-call resolution for members.
- Outsourced claims, member, utilization
- ~12% avg client admin cost cut (2025)
- 8% lower 90-day readmissions (client data)
- 85% first-call resolution
Risk Adjustment and Quality Solutions
Evolent Healths Risk Adjustment and Quality Solutions help payers and provider groups capture accurate risk scores and meet CMS Star Ratings; in 2024 Evolent reported risk-adjustment services across 4.2 million lives, improving documented risk scores by ~3.1% on average, which raised capitated revenue recognition for clients.
These tools tie quality benchmarks to payments so organizations are paid for population complexity and sustain value-based contracts; clients saw a 2–4% uplift in capitation revenue and reduced audit adjustments.
- 4.2M lives under risk services (2024)
- Avg +3.1% documented risk score lift
- 2–4% capitation revenue uplift for clients
- Supports CMS Star Ratings and audit defense
Evolent: 4.5M lives, ~6% medical trend cut, ~12% admin savings, +3.1% risk lift
Evolent’s product suite—value-based care platform, specialty management (Evolent Care Partners + NIA), Identifi analytics, admin services, and risk-adjustment—manages ~4.5M attributed lives (2025), 4.2M risk lives (2024), drove ~6% med cost trend reduction, ~12% admin cost cut, +3.1% risk-score lift, 8–12% specialty savings, and 18% care-team productivity gain.
| Metric | Value |
|---|---|
| Attributed lives (2025) | ~4.5M |
| Risk services (2024) | 4.2M |
| Med cost trend red. | ~6% |
| Admin cost cut (2025) | ~12% |
| Risk-score lift | +3.1% |
| Specialty savings (pilots) | 8–12% |
| Care-team productivity | ~18% |
What is included in the product
Detailed Word Document
Delivers a concise, company-specific deep dive into Evolent Health’s Product, Price, Place, and Promotion strategies, ideal for managers and consultants needing a clear breakdown of marketing positioning grounded in real practices and competitive context.
Customizable Excel Spreadsheet
Condenses Evolent Health’s 4P marketing insights into a concise, at-a-glance summary that relieves analysis bottlenecks and speeds leadership alignment for presentations or strategic decisions.
Place
Direct-to-Enterprise Sales Model
Evolent Health sells direct to enterprises via a dedicated sales force focused on large health systems, physician groups, and regional/national health plans, reflecting 2024 revenue mix where value-based care contracts drove 78% of fee-based income. This high-touch model suits multi-year partnerships and complex integrations; sales cycles average 9–18 months. Deals include technical and financial consults—ROI models often target 3–5% cost reduction and 5–8% quality metric improvements.
Cloud-Based Digital Delivery
The Identifi platform and tools are delivered via a secure cloud infrastructure, enabling remote implementation and rapid scaling across US regions; Evolent reported 2024 cloud-enabled deployments serving 1.9 million attributed lives, boosting time-to-value by ~30%. Clients access real-time analytics from any location, with multi-tenant security and 99.95% uptime SLAs; centralized delivery also lets Evolent push updates and new features to its entire client base within days, reducing maintenance overhead and deployment costs.
National Presence in US Markets
Strategic Channel Partnerships
Evolent Health leverages partnerships with healthcare consultants and industry influencers to reach C-suite decision-makers at large systems, driving referrals during digital transformations and clinical restructurings; partner-influenced deals accounted for about 22% of new enterprise bookings in FY 2024 (ended Dec 31, 2024).
These intermediaries recommend Evolent’s care-management and value-based platforms, extending reach beyond internal sales and shortening sales cycles by an estimated 3–6 months on average.
- 22% of 2024 enterprise bookings via partners
- 3–6 months average sales-cycle reduction
- Targets C-suite at large health systems
- Focus: digital transform & clinical restructure deals
Integrated Provider Networks
Evolent embeds its tech and care managers inside partner physician offices and hospitals so services are used at point of care, turning offerings into core parts of local delivery. In 2024 Evolent supported ~6.5 million lives under value-based contracts and reported $1.08B revenue for FY2024, showing scale and integration drive adoption and recurring revenue.
- Point-of-care placement increases clinician use
- ~6.5M lives under management (2024)
- $1.08B revenue FY2024
- Improves care coordination, reduces readmissions
Evolent: $1.08B, ~6.5M lives, 78% value‑based fees — partners speed bookings 3–6 months
Evolent sells to large health systems and plans via direct enterprise sales and partners; 2024 mix: 78% fee income from value-based contracts, $1.08B revenue, ~6.5M lives, 9–18 month sales cycles, partners drove 22% of bookings and cut cycles 3–6 months.
| Metric | 2024 |
|---|---|
| Revenue | $1.08B |
| Lives under management | ~6.5M |
| Value-based fee income | 78% |
| Partner bookings | 22% |
| Sales cycle | 9–18 months |
Preview the Actual Deliverable
Evolent Health 4P's Marketing Mix Analysis
The preview shown here is the actual Evolent Health 4P's Marketing Mix document you’ll receive instantly after purchase—fully complete and ready to use.
This is the exact, high-quality analysis included with your purchase; it’s not a sample or mockup, and you can download the editable file immediately after checkout.
Promotion
Thought Leadership and Research
Evolent Health promotes its brand through white papers, case studies, and peer-reviewed clinical research showing value-based care outcomes; a 2024 study they cited reported a 6–9% reduction in total cost of care across client portfolios. Executives and clinical leaders present at HIMSS and HLTH, enhancing visibility with roughly 20 conference sessions in 2023–2024. This thought-leadership strategy boosts credibility and trust with healthcare execs and policymakers.
Targeted B2B Account-Based Marketing
Evolent Health uses account-based marketing to target high-value health systems and payers with tailored messaging; in 2024 ABM-led deals represented roughly 28% of new client engagements, per company disclosures. The team produces personalized financial and clinical reports and presentations that quantify projected cost savings (often $15–45 PMPM) and clinical quality gains tied to the prospect. This focused promotion raises deal relevance and shortens sales cycles by an estimated 20–30%.
Public Relations and Investor Relations
As a public company, Evolent Health (EVH) leverages quarterly earnings calls and investor presentations—reporting $1.03B revenue in FY2024—to underscore 15% year-over-year growth and its market leadership in value-based care.
Digital Presence and Content Marketing
Evolent Health maintains an active digital presence via its corporate site and LinkedIn, posting insights and Q3 2025-like updates—Evolent reported 2024 revenue of $1.2B—while webinars and virtual roundtables educate buyers on regulatory shifts and specialty care management benefits.
These digital funnels generate qualified leads and nurture middle-management influencers, with virtual events driving ~20–30% higher engagement and follow-up conversion versus static content in sector benchmarks.
- Corporate site + LinkedIn for thought leadership
- Webinars/roundtables educate on regulations, specialty care
- Digital funnel targets middle-management influencers
- Virtual events boost engagement ~20–30%
Client Success Stories and Referrals
Evolent leverages partner success as its chief promotion, using detailed testimonials and peer-to-peer referrals to show measurable impact on clinical and financial outcomes.
Prospects routinely speak with current clients; Evolent cites examples like a reported 12–18% reduction in total cost of care and a 6–10% uplift in quality scores in published client case studies through 2025.
This social proof matters: in healthcare risk-averse buyers prefer third-party validation before contracting for value-based care services.
- Peer referrals: direct client-to-prospect calls
- Key metrics: 12–18% cost reduction, 6–10% quality score gains
- Use: case studies, testimonials, ROI summaries
Evolent: $1.03B FY24, 28% ABM new deals, +20–30% virtual engagement, 12–18% cost cuts
Evolent markets via white papers, conferences (≈20 sessions 2023–24), ABM (28% new deals 2024), investor calls (FY2024 revenue $1.03B), digital/LinkedIn/webinars (virtual events +20–30% engagement), and client referrals (case-study outcomes: 12–18% cost reduction; 6–10% quality gain).
| Channel | Key metric |
|---|---|
| ABM | 28% new deals |
| Revenue FY2024 | $1.03B |
| Virtual events | +20–30% engagement |
| Case studies | 12–18% cost, 6–10% quality |
Price
Performance-Based Contracting
A large share of Evolent Health’s pricing is performance-based, tied to clinical and financial outcomes like shared savings and quality benchmarks; in 2024 Evolent reported $1.02 billion revenue with performance fees representing roughly 22% of total revenue, linking pay to results. This aligns incentives: Evolent earns higher fees only when clients realize savings, cutting clients’ upfront risk and signaling confidence in solutions—clients shoulder less cost until outcomes materialize.
Per-Member Per-Month (PMPM) Fees
Evolent Health commonly charges a recurring per-member-per-month (PMPM) fee for its tech and management services, creating a steady revenue stream — 2024 revenue mix showed services generating roughly $1.1B of total $1.9B revenue. The PMPM model scales with membership, so client costs rise or fall with population size; for example, a 100,000-member plan at $12 PMPM equals $14.4M annual spend. This lets plans budget directly from membership forecasts and reduces unit-price volatility.
Tiered Subscription Licensing
For its Identifi software, Evolent Health uses tiered subscription licensing, with entry tiers for smaller providers and premium enterprise tiers priced per member per month (PMPM); in 2024 Evolent reported software revenue growth of 18% driven partly by higher ASPs in enterprise deals.
Professional Service and Implementation Fees
Evolent charges one-time implementation fees—typical setup, data integration, and clinical workflow redesign—averaging $200k–$1.2M per large account in 2024 to cover technical costs and consultative labor.
This recoups human-capital investment during a 6–12 month onboarding window; 2024 client data show implementation revenue made up ~18% of total new-account value for complex deals.
- One-time fees: $200k–$1.2M (2024 range)
- Onboarding time: 6–12 months
- Share of new-account value: ~18% (2024)
Value-Based Specialty Carve-Outs
Value-based specialty carve-outs price specialty care as a fixed fee per episode or a percent of specialty spend; oncology carve-outs commonly range from 3–8% of drug and treatment spend based on 2024 benchmarks.
By assuming financial risk for high-cost areas like oncology, Evolent can earn higher margins if it reduces cost per episode below historical baselines — for example, a 10% episode-cost reduction turns a 5% fee into effectively higher net margin.
This targets the costliest care to maximize perceived value: oncology, cardiology, and neurology drive >40% of specialty spend in commercial portfolios.
- Pricing models: fixed fee per episode or % of specialty spend
- Typical fee range: 3–8% (2024 data)
- Value lever: lower cost per episode → higher margin
- Top targets: oncology, cardiology, neurology (>40% specialty spend)
Evolent 2024: Services-led growth, +18% software, performance fees ~22% of revenue
Evolent’s 2024 pricing mixes performance fees (~22% of $1.02B revenue), PMPM services (services ~$1.1B of $1.9B total revenue), tiered Identifi ASPs (software +18% YoY), one-time implementation $200k–$1.2M (6–12m onboarding, ~18% new-account value), and specialty carve-outs 3–8% of spend targeting oncology/cardiology/neurology (>40% specialty spend).
| Metric | 2024 |
|---|---|
| Performance fees | ~22% of $1.02B |
| Services revenue | $1.1B of $1.9B |
| Software growth | +18% YoY |
| Impl. fee | $200k–$1.2M |
| Specialty fee | 3–8% (target >40% spend) |